Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: South Africa Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20061
20071
20081
20091
20102
20113
20123
20132
20141
20151
20161
20181
20191
20232
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated7
Recruiting5
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
GlaxoSmithKline4
AstraZeneca3
Eli Lilly and Company2
Pfizer2
Sanofi2
Alnylam Pharmaceuticals1
Amarin Pharma Inc.1
Amgen1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases30
Myocardial Infarction9
Stroke8
Acute Coronary Syndrome5
Diabetes Mellitus, Type 25
Heart Diseases5
Hyperlipidemias5
Atherosclerosis4
Dyslipidemias4
Heart Failure4

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.